Jun Hanaoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Hanaoka has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Masayuki Hashimoto
Department of Surgery, Shiga University of Medical Science Shiga University of Medical Science Otsu Shiga Japan
4 shared publications - Kazuki Hayashi
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
3 shared publications - Koji Teramoto
Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Seta-Tsukinowa, Otsu, Japan
3 shared publications Ryosuke Kaku
Department of Surgery, Shiga University of Medical Science
3 shared publicationsTomoyuki Igarashi
Department of Surgery, Shiga University of Medical Science
3 shared publicationsYasuhiko Oshio
Department of Thoracic Surgery, Shiga University of Medical Science
3 shared publications
Latest Publications
- 1 January 2017
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 31 (2) , 233-237
A case of thymic basaloid carcinoma
- 1 January 2017
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 31 (2) , 233-237
A case of thymic basaloid carcinoma
- 1 January 2016
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 30 (2) , 153-158
A case of pulmonary pleomorphic carcinoma with an extremely poor prognosis
- 1 January 2016
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 30 (2) , 153-158
A case of pulmonary pleomorphic carcinoma with an extremely poor prognosis
- 1 April 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (4) , e85-e86
Invasive Desmoplastic Fibroblastoma in the Chest Wall
- 1 April 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (4) , e85-e86
Invasive Desmoplastic Fibroblastoma in the Chest Wall
- 1 January 2015
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 29 (5) , 600-604
A case of hyaline vascular type of Castleman's disease resected by L-shaped mini-sternotomy with a supraclavicular approach: Poly-lymphadenopathy with difficulty in making a definite diagnosis
- 1 January 2015
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 29 (5) , 600-604
A case of hyaline vascular type of Castleman's disease resected by L-shaped mini-sternotomy with a supraclavicular approach: Poly-lymphadenopathy with difficulty in making a definite diagnosis
- 1 December 2014
- Vol. 67 (13) , 1198-200
[Resection of double bronchogenic cysts within the anterior mediastinum; report of a case].
We reported a case of surgically resected double bronchogenic cysts within the anterior mediastinum. An anterior mediastinal tumor had been found at medical examination 6 years ago in a 66-year-old man, but has been followed up without treatment. After the treatment of another disease, he was referred to our hospital for evaluation of the mediastinal tumor. A chest computed tomography showed 2 anterior mediastinal nodules. Nodules in the thymus were resected with video-assisted thoracic surgery. The tumors were both pathologically diagnosed as bronchogenic cysts.
- 1 December 2014
- Vol. 67 (13) , 1198-200
[Resection of double bronchogenic cysts within the anterior mediastinum; report of a case].
We reported a case of surgically resected double bronchogenic cysts within the anterior mediastinum. An anterior mediastinal tumor had been found at medical examination 6 years ago in a 66-year-old man, but has been followed up without treatment. After the treatment of another disease, he was referred to our hospital for evaluation of the mediastinal tumor. A chest computed tomography showed 2 anterior mediastinal nodules. Nodules in the thymus were resected with video-assisted thoracic surgery. The tumors were both pathologically diagnosed as bronchogenic cysts.
- 1 September 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (3) , e67-e68
Superior Sulcus Tumor Resection With Multiple Pulmonary Arteriovenous Fistulas
- 1 September 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (3) , e67-e68
Superior Sulcus Tumor Resection With Multiple Pulmonary Arteriovenous Fistulas
- 1 November 2002
- Published by Springer Nature in Surgery Today
- Vol. 32 (11)
Mediastinal cavernous hemangioma in a child: report of a case.
We present herein a rare case of mediastinal cavernous hemangioma in a 5-year-old boy. The patient was referred to our hospital for an evaluation of cough and high fever. On admission, a chest computed tomogram and magnetic resonance imaging revealed a large tumor arising from the left-sided mediastinum which compressed the left main pulmonary artery and left lung. The tumor, measuring 105 x 60 x 60 mm in size and weighing 170 g, was completely resected without any major bleeding, and a pathological examination confirmed the diagnosis of cavernous hemangioma.
- 1 November 2002
- Published by Springer Nature in Surgery Today
- Vol. 32 (11)
Mediastinal cavernous hemangioma in a child: report of a case.
We present herein a rare case of mediastinal cavernous hemangioma in a 5-year-old boy. The patient was referred to our hospital for an evaluation of cough and high fever. On admission, a chest computed tomogram and magnetic resonance imaging revealed a large tumor arising from the left-sided mediastinum which compressed the left main pulmonary artery and left lung. The tumor, measuring 105 x 60 x 60 mm in size and weighing 170 g, was completely resected without any major bleeding, and a pathological examination confirmed the diagnosis of cavernous hemangioma.
- Open Access
Expression and immunogenicity of a tumor‐associated antigen, 90K/Mac‐2 binding protein, in lung carcinoma
BACKGROUND The authors attempted to obtain shared proteins among lung carcinoma cells by column chromatographies. A glycoprotein with approximately 500 kDa isolated from QG56 cells showed an identical amino acid sequence to 90K/Mac‐2 binding protein (M2BP). This protein has been reported to be highly expressed and to modulate the expression of surface molecules involved in immune responses on cultured cancer cells. Therefore, it would be beneficial for M2BP to be targeted in cancer immunotherapy. METHODS The authors analyzed the expression of M2BP in lung carcinoma cells and M2BP's immunogenicity as a tumor antigen. Eight cultured lung carcinoma cell lines and 28 tumor tissues from patients with lung carcinoma were examined for the expression of M2BP mRNA and protein. Sera from cancer patients (n = 23) and healthy donors (n = 19) were studied for their reactivity to M2BP peptides by enzyme–linked immunosorbent assay. RESULTS Seven of the 8 (87.5%) lung carcinoma cell lines and 17 of the 28 (60.7%) tumor tissues expressed high levels of M2BP mRNA. Most of the M2BP mRNA‐positive cancer cell lines and tumors also showed M2BP protein expression. The serum levels of antibodies to M2BP were elevated in 30.4% of the patients. In addition, M2BP‐specific immunoglobulin G was observed in all patients with anti‐M2BP antibodies. CONCLUSIONS M2BP is highly expressed in lung carcinoma cells and is sufficiently immunogenic to elicit specific immunity to this molecule in patients with lung carcinoma. M2BP is expected to be useful as a tumor marker and a target antigen in cancer immunotherapy. Cancer 2002;95:1954–62. © 2002 American Cancer Society. DOI 10.1002/cncr.10899
Open AccessExpression and immunogenicity of a tumor‐associated antigen, 90K/Mac‐2 binding protein, in lung carcinoma
BACKGROUND The authors attempted to obtain shared proteins among lung carcinoma cells by column chromatographies. A glycoprotein with approximately 500 kDa isolated from QG56 cells showed an identical amino acid sequence to 90K/Mac‐2 binding protein (M2BP). This protein has been reported to be highly expressed and to modulate the expression of surface molecules involved in immune responses on cultured cancer cells. Therefore, it would be beneficial for M2BP to be targeted in cancer immunotherapy. METHODS The authors analyzed the expression of M2BP in lung carcinoma cells and M2BP's immunogenicity as a tumor antigen. Eight cultured lung carcinoma cell lines and 28 tumor tissues from patients with lung carcinoma were examined for the expression of M2BP mRNA and protein. Sera from cancer patients (n = 23) and healthy donors (n = 19) were studied for their reactivity to M2BP peptides by enzyme–linked immunosorbent assay. RESULTS Seven of the 8 (87.5%) lung carcinoma cell lines and 17 of the 28 (60.7%) tumor tissues expressed high levels of M2BP mRNA. Most of the M2BP mRNA‐positive cancer cell lines and tumors also showed M2BP protein expression. The serum levels of antibodies to M2BP were elevated in 30.4% of the patients. In addition, M2BP‐specific immunoglobulin G was observed in all patients with anti‐M2BP antibodies. CONCLUSIONS M2BP is highly expressed in lung carcinoma cells and is sufficiently immunogenic to elicit specific immunity to this molecule in patients with lung carcinoma. M2BP is expected to be useful as a tumor marker and a target antigen in cancer immunotherapy. Cancer 2002;95:1954–62. © 2002 American Cancer Society. DOI 10.1002/cncr.10899